Latest Breaking News On - Karolinska development ab nasdaq stockholm - Page 1 : vimarsana.com

Karolinska Development invests in BOOST Pharma, expanding its portfolio

Karolinska Development invests in BOOST Pharma, expanding its portfolio
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Karolinska institutetViktor drvotaJohan dighedKarolinska development ab nasdaq stockholmKarolinska developmentNasdaq stockholmRare pediatric diseaseOrphan drug designationGeneral counsel

Karolinska Development s Annual General Meeting 2024

STOCKHOLM, SWEDEN – May 16, 2024. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held the Annual General Meeting on May 16, 2024. The shareholders have had the right to exercise their voting rights in advance through postal voting pursuant to item 13 in the articles of association. Therefore, shareholders have had the choice to exercise their voting rights at the AGM by attending in person, by postal voting or through a proxy. The following resolutions were passed b

Philip duongKarolinska institutetJohan dighedTheresa tseErnst young aktiebolagViktor drvotaHans wigzellAnna lefevre skjBen toogoodNomination committeeKarolinska development ab nasdaq stockholmKarolinska developmentSwedish companiesAppropriation of the companyAnnual general meetingYoung aktiebolag

Karolinska Development s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC

Karolinska Development s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Umecrine cognitionsViktor drvotaKarolinska institutetJohan dighedKarolinska development ab nasdaq stockholmKarolinska developmentNasdaq stockholmUmecrine cognitionPrimary biliary cholangitisGeneral counsel

Interim Report - January-March 2024

STOCKHOLM – 26 April 2024. Karolinska Development AB today publishes its Interim Report - January-March 2024. The full report is available on the Company s website. “2024 has begun strongly with.

Karolinska institutetViktor drvotaKarolinska development ab nasdaq stockholmKarolinska developmentInternational conference on alzheimerNasdaq stockholmInterim reportOssdsign catalystUmecrine cognitionInternational conferenceAprea therapeuticsInvestigational new drug applicationPrimary biliary cholangitisModus therapeutics

Year-end Report - January-December 2023

STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company s website. “2023 has been a year.

Viktor drvotaKarolinska institutetKarolinska development ab nasdaq stockholmUs national institute of drug abuseLiver internationalKarolinska developmentNasdaq stockholmYear end reportModus therapeuticsUmecrine cognitionDrug abuseDelta opioid receptor agonistOssdsign catalyst